The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

Dr. Ribas Adoptive Cell Therapy with a new twist.

Forums General Melanoma Community Dr. Ribas Adoptive Cell Therapy with a new twist.

  • Post
    ed williams
    Participant
      When melanoma patients choose TIL’s they normally get IL-2 after chemo depletion to rev the immune system up so that when they get the TIL’s infusion, the IL-2 will help prime the immune system so the T-cell will get into the melanoma tumor cells. NKTR-214 has been in clinical trial (Pivot 02 trial) for a couple of years in combination with Pd-1 Nivolumab. They now called NKTR-214 “Bempegaldesleukin” which is old school IL-2 with a twist of being pegylated which reduces the toxicity compared with old school IL-2. Now, while we are still waiting for data on NKTR-214 + nivo to see if early trial results hold up, it does make sense to use it in TIL’s. Here is a new research article from UCLA and Dr. Ribas, where they are developing a new twist to TIL’s and hopefully in the near future it will be available for those who fail Immunotherapy or targeted therapy or maybe even a first line treatment approach one day. https://cancer.ucla.edu/Home/Components/News/News/1442/1631
    Viewing 2 reply threads
    • Replies
    Viewing 2 reply threads
    • You must be logged in to reply to this topic.
    About the MRF Patient Forum

    The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

    The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

    Popular Topics